by the preparation of the consolidated financial statements. 3. Reversal of provisions for litigation The decrease from the same period last year by 10.88 million baht due to Q2 2016 Reversal of

of 107.97 million Baht. For the Separate Financial Statements of the Company for the nine-month period in 2017, the Company had total revenue of 125.69 million Baht and profit amounted to 44.95 million

November 2018, approving the audited consolidated financial statements for Quarter 3 of 2018 ending on 30 September 2018. The Company would like to report factors that affect the financial performance of the

statements for the 3-month period and 6-month period ending June 30, 2018 as follows. The net profit of the Corporate Group for the 3-month period and 6-month period ending June 30, 2018 were Baht 115.58

2018. Cost of Sales and Gross Profit Cost of sales for 2019 was THB 14,443. 47 million, increased by THB 179. 91 million or 1. 26% up from 2018 while gross profit in 2019 was THB 2,420. 27 million, rose

statements for the 3-month period and 9-month period ending September 30, 2017 as follows. The net profit of the Corporate Group for the 3-month period and 9-month period ending September 30, 2017 were Baht

0 ] Ref. No. IVL 001/05/2021 6 May 2021 The President The Stock Exchange of Thailand Subject: Submission of Quarterly Review of Financial Statements and the Management Discussion and Analysis of

and 0.39 million in consolidated income statements respectively. 1.7 Earning (loss) before interest and tax and Net Profit (loss) For the period of three months and period of 1st half ended 30th Sept

audited by the independent auditor as follows: Statements of Comprehensive Income for the Fourth Quarter and Year Ended December 31, 2017 Note: During 1Q17, the Company’s subsidiary has recorded income

Thailand The Board of Directors’ Meeting of Ladprao General Hospital Public Company Limited (the “Company”), No.2/2018, held on May 11, 2018, has approved the financial statements of the Company and its